# The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA

> **NCT04519489** · NA · TERMINATED · sponsor: **Philips (China) Investment CO., LTD** · enrollment: 129 (actual)

## Conditions studied

- Atrial Fibrillation
- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** PAP therapy with telemonitoring
- **OTHER:** AF standard management and OSA general care

## Key facts

- **NCT ID:** NCT04519489
- **Lead sponsor:** Philips (China) Investment CO., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-18
- **Primary completion:** 2021-12-24
- **Final completion:** 2021-12-24
- **Target enrollment:** 129 (ACTUAL)
- **Why stopped:** Sponsor and investigators aligned to terminate this study.
- **Last updated:** 2025-09-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519489, "The Efficacy of PAP Therapy on Reducing AF Recurrence in Patients With Morbidity of OSA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04519489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*